Login or Sign Up
15:59 Apr 29
Cipla Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Cipla Ltd.
88/100 High Financial Strength
Quality38/100 Mid Valuation
Valuation55/100 Technically Neutral
TechnicalSWOT
Strength
16
Weakness
1
Opportunity
1
Threat
0
1.24L
Market Cap (Cr)
24.95
PE Ratio
4.39
Price to Book Ratio
58.71
RSI
15.99 %
Net Profit Margin
Rating Based on 10 Analysts
Buy
60%
Hold
40%
Sell
0%
Buy
Analyst Price Target
The average price target is 1707.3 with a high estimate of 1808 and low estimate of 1530
Current 1541.50
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
